[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR2755013B1 - NEW THERAPEUTIC APPLICATION OF P SUBSTANCE ANTAGONISTS - Google Patents

NEW THERAPEUTIC APPLICATION OF P SUBSTANCE ANTAGONISTS

Info

Publication number
FR2755013B1
FR2755013B1 FR9613175A FR9613175A FR2755013B1 FR 2755013 B1 FR2755013 B1 FR 2755013B1 FR 9613175 A FR9613175 A FR 9613175A FR 9613175 A FR9613175 A FR 9613175A FR 2755013 B1 FR2755013 B1 FR 2755013B1
Authority
FR
France
Prior art keywords
new therapeutic
therapeutic application
substance antagonists
antagonists
substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9613175A
Other languages
French (fr)
Other versions
FR2755013A1 (en
Inventor
Assunta Imperato
Saliha Moussaoui
Carmen Obinu
Olivier Gobbo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Priority to FR9613175A priority Critical patent/FR2755013B1/en
Priority to PCT/FR1997/001914 priority patent/WO1998018465A1/en
Priority to AU49514/97A priority patent/AU4951497A/en
Publication of FR2755013A1 publication Critical patent/FR2755013A1/en
Application granted granted Critical
Publication of FR2755013B1 publication Critical patent/FR2755013B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR9613175A 1996-10-29 1996-10-29 NEW THERAPEUTIC APPLICATION OF P SUBSTANCE ANTAGONISTS Expired - Fee Related FR2755013B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR9613175A FR2755013B1 (en) 1996-10-29 1996-10-29 NEW THERAPEUTIC APPLICATION OF P SUBSTANCE ANTAGONISTS
PCT/FR1997/001914 WO1998018465A1 (en) 1996-10-29 1997-10-24 Use of antagonists of substance p for treating tardive diskinesia
AU49514/97A AU4951497A (en) 1996-10-29 1997-10-24 Use of antagonists of substance p for treating tardive diskinesia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9613175A FR2755013B1 (en) 1996-10-29 1996-10-29 NEW THERAPEUTIC APPLICATION OF P SUBSTANCE ANTAGONISTS

Publications (2)

Publication Number Publication Date
FR2755013A1 FR2755013A1 (en) 1998-04-30
FR2755013B1 true FR2755013B1 (en) 1998-11-27

Family

ID=9497133

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9613175A Expired - Fee Related FR2755013B1 (en) 1996-10-29 1996-10-29 NEW THERAPEUTIC APPLICATION OF P SUBSTANCE ANTAGONISTS

Country Status (3)

Country Link
AU (1) AU4951497A (en)
FR (1) FR2755013B1 (en)
WO (1) WO1998018465A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU734872B2 (en) * 1996-12-02 2001-06-21 Merck Sharp & Dohme Limited Use of NK-1 receptor antagonists for treating movement disorders
US6156749A (en) * 1997-12-01 2000-12-05 Merck Sharp & Dohme Limited Use of NK-1 receptor antagonists for treating movement disorders
RU2278612C2 (en) 2000-07-14 2006-06-27 Лайфскен, Инк. Immune sensor
US20060134713A1 (en) 2002-03-21 2006-06-22 Lifescan, Inc. Biosensor apparatus and methods of use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2654726B1 (en) * 1989-11-23 1992-02-14 Rhone Poulenc Sante NEW ISOINDOLONE DERIVATIVES AND THEIR PREPARATION.
US5216018A (en) * 1992-02-14 1993-06-01 Du Pont Merck Pharmaceutical Company Hydroisoindolines and hydroisoquinolines as psychotropic
EP0634402A1 (en) * 1993-07-14 1995-01-18 Takeda Chemical Industries, Ltd. Isochinolinone derivatives, their production and use
US5541217A (en) * 1995-05-17 1996-07-30 Ortho Pharmaceutical Corporation 4-arylcyclopenta[c]pyrrole analgesics

Also Published As

Publication number Publication date
FR2755013A1 (en) 1998-04-30
WO1998018465A1 (en) 1998-05-07
AU4951497A (en) 1998-05-22

Similar Documents

Publication Publication Date Title
DE69831755D1 (en) OPTOACUSTIC CONSTANCES AND METHOD OF USE
PT1032396E (en) STERILIZATION OF GLUCOCORTICOESTEROIDS
BR9607791A (en) Oral formulation of 2-methyl-thieno-benzodiazepine
PT907364E (en) PHARMACEUTICAL COMPOSITION OF SUSTAINED LIBERTACAO
DE69821072D1 (en) Real-time image-controlled positioning of anchoring units
PT861081E (en) USING EPINASTINE FOR THE TREATMENT OF PAIN
ITMI961087A0 (en) DISTRIBUTOR OF CREAMY SUBSTANCES
ID18679A (en) USE OF FURTHER THERAPY
PT754407E (en) LIQUID FORMULATIONS OF 1,2-BENZISOYLAZOLIN-3-ONA
BR9505382A (en) Use of at least one substance P antagonist
FR2757059B1 (en) NEW THERAPEUTIC APPLICATION OF PYRROLE DERIVATIVES
FI973229A (en) New pharmaceutical composition
ID24270A (en) REMOVAL OF KERATOTIC CONSTITIONS
BR9609081A (en) Combinations of active substances
IS4597A (en) New pharmaceutical use of AII receptor antagonists
FR2755013B1 (en) NEW THERAPEUTIC APPLICATION OF P SUBSTANCE ANTAGONISTS
ID23437A (en) REMOVAL OF KERATOTIC CONSTITIONS
NO982562D0 (en) Composition for the treatment of pain
KR970057131U (en) Supply device of forging material
FR2756738B1 (en) NEW THERAPEUTIC APPLICATION OF A THIENYLCYCLOHEXYLAMINE DERIVATIVE
FR2691359B1 (en) NEW THERAPEUTIC APPLICATION OF 1-CITRULLINE MALATE.
BR9708484A (en) Application of substituted arylimidazoles
BR9604995A (en) New uses of heptafluoropropane
ID24439A (en) USE OF TIAZOLIDINDION FOR HYPERGLICEMIA TREATMENT
NO993069D0 (en) New use of dipeptides

Legal Events

Date Code Title Description
ST Notification of lapse